Home > Clinical Research
Clinical Research

G7 SYNERGON, the fastest-growing integrated Contract Research Organization (CRO), offers end to end clinical research services to the pharma, biotech and medical device industries. We focus on saving time for the early delivery of the drug to market which is possible by our strong Quality Management System (QMS). We have years of experience and expertise in research as well as a passion for science in providing quality solutions to support projects. We enjoy an enviable reputation since the majority of our work is based on repeat business from our satisfied clients. The key to our success is dedication towards providing quality services to our clients.

Services

Our systems are developed to meet several regulatory norms across the globe. We are staffed with 100 + employees, backed up with strong experience in the areas of project management.



Clinical Operation

G7 Synergon’s Clinical Operations team conducts Phases II-IV clinical trials by maintaining the highest standards of ethics, quality and confidentiality. We promote a team approach with emphasis on

 
Clinical Data Management

G7 Synergon has an experienced data management team which recognizes the importance of a smooth interface with CRAs, Project Managers, clients and Investigational sites. We ensure that the clinical data

 
Medical writing

We provide an extensive range of high quality medical writing services to our clients. Our medical writing team comprises highly qualified personnel mainly from the medical and pharmaceutical

 
Pharmacovigilance

G7 Synergon provides pharmacovigilance services for product safety for pre- marketing and post-marketing of drugs. We have a dedicated team of trained pharmacovigilance specialists and

 
Medical monitoring

At G7 Synergon we understand that safety is of primary concern during all phases of clinical research. Our medical monitors provide medical review and management of clinical trial activities for our clients.All our monitors

 
Biometrics

Our statisticians and programmers analyze data for endpoint determination, perform statistical procedures and evaluation criteria, customized programming services and data display formats as per regulatory requirements.

 
Regulatory affairs

Bringing a new product from its development to marketing approval is an expensive and lengthy process. If unanticipated delays occur, costs in both time and money can rapidly escalate.The staffs at G7 Synergon are

 
Quality assurance

The Quality Assurance group at G7 Synergon is one of the key drivers ensuring that the quality of the services match the global standards. Our independent Quality Assurance Unit provides audit

 


News

Post Marketing Clinical (PMC)

Phase IV Studies – A Market With A Proactive Approach For Growth Of A Pharmaceutical Busine...

CHRONICLE PHARMABIZ

India, an emerging global hub for vaccine industry ASIA is emerging as the vaccine hub ...

Vaccine Industry in India – An Emerging Global Hub

Asia is emerging as the vaccine hub of the world and India is on the go to play a key role in the...

RECOGNITIONS

“G7 SYNERGON has been recognized by the Department of Scientific and Industrial Research (D...

G7 Group Companies

News Letter

Counter :mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
© 2010 G7 SYNERGON. All rights Reserved